From science-backed supplements to insurance-covered nutrition therapy, here's your complete guide to effective weight loss ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Novo Holdings plans to double its newly acquired contract drugmaker, Catalent, within five years, focusing on U.S. manufacturing. The $16.5 billion acquisition is aimed at enhancing supply chains amid ...

Ozempic and Wegovy have become popular options for people looking to lose weight, but there are some risks and side effects ...

The Elcella pill unlocks the body’s naturally occurring hormones in the colon, to send ‘fullness’ messages to the brain, ...

Pharmaceutical giants Eli Lilly and Novo Nordisk, makers of Zepbound and Wegovy, respectively, have filed lawsuits against medical spas, weight-loss clinics, and compounding pharmacies they accuse of ...

Eli Lilly expects its experimental weight loss pill, orforglipron, to receive approval as early as next year, CEO David Ricks told Bloomberg Jan. 13, according to a Wall Street Journal report.

Weight-loss drugs such as Ozempic and Wegovy are increasingly popular among adults, who have flocked to the new medications as alternatives to the traditional — and often ineffective — advice ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

Users on TikTok have touted the benefits of taking berberine supplements, claiming benefits for weight loss, heart health and more. Do you need them?